Market Place
Sourcing Support
Trogenix Doses First Patient in Ph I/II Clinical Trial of TGX-007
28 May 2026 //
GLOBENEWSWIRE
Trogenix Unveils Breakthrough Brain Cancer Data in Nature
08 Apr 2026 //
GLOBENEWSWIRE
Trogenix Raises 70M Series A To Advance Curative Cancer Therapies
06 Oct 2025 //
GLOBENEWSWIRE
Trogenix Appoints Atif Abbas as CMO, Carolyn as VP
18 Jul 2025 //
GLOBENEWSWIRE
Trogenix strengthens Board with Prof Nada & Prof Burkhard
07 May 2025 //
GLOBENEWSWIRE
Viralgen partners Trogenix to AAV gene therapy for glioblastoma
06 May 2025 //
PR NEWSWIRE
Copyright © 2026 LePro PharmaCompass OPC Private Limited, All rights reserved.